Showing Results for: “diabetes exercise”

The American Diabetes Association (ADA) welcomes the 2020 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking, innovative medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence. "We are thrilled to welcome the newest members of ADA’s National Board of Directors,” said Tracey D. Brown, Chief Executive Officer of the ADA. “With the help of these talented and dedicated experts, we will continue the important work that leads us closer and

This World Diabetes Day, Know Diabetes by Heart™ national spokespeople spotlight the link between type 2 diabetes and cardiovascular disease Today, on World Diabetes Day, the American Heart Association and the American Diabetes Association, two of the world’s leading health organizations in the areas of cardiovascular diseases and diabetes, announce new patient spokespeople for Know Diabetes by Heart ™ , a joint initiative to inspire more than 30 million Americans living with diabetes to lower their risk for cardiovascular death, heart attacks, heart failure and stroke. Five ambassadors and

The American Diabetes Association (ADA) is honored to welcome the 2019 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence. "The newest members of ADA’s National Board of Directors are respected and trusted leaders within their professions, and we are thankful they are willing to share their time and energy to help us bend the curve on the diabetes epidemic,” said Tracey D. Brown, Chief

The American Diabetes Association® (ADA) applauds Georgia Governor Brian P. Kemp for signing a bill allowing a broader population of Georgia’s Medicaid beneficiaries to be eligible for a continuous glucose monitor (CGM), a big win for those diagnosed with diabetes who are insulin dependent. CGMs continually monitor blood glucose (blood sugar), giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a lower A1C, an important indicator of glucose management. The

American Diabetes Association Symposium Showcases New Potential Solution for Patients at High-Risk of Kidney Outcomes Today, findings from the landmark FLOW trial, the first dedicated kidney outcomes trial with a GLP-1 (glucagon-like peptide-1) receptor agonist were reported, demonstrating semaglutide significantly reduces the risk of major kidney disease events and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease. New data presented here also highlighted the likely benefits of combined therapy with SGLT2 inhibitors. The results were presented at a symposium

A new consensus report addressing the benefits, challenges, and recommendations related to automated insulin delivery (AID) is being jointly published today by two leading diabetes organizations: the American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD). The ADA and the EASD convened a joint Diabetes Technology Working Group to review the current landscape of AID systems and recommend targeted actions. “The report addresses the clinical usage of AID systems from a practical point of view rather than as a meta-analysis or a review of all relevant

Yesterday, Maryland Governor Lawrence (Larry) Hogan, Jr. signed Senate Bill 353 and House Bill 1397 – a critical action that will help save lives and reduce the burden of insulin costs for people living with diabetes in Maryland. The American Diabetes Association® (ADA) applauds Governor Hogan for signing the legislation that will cap copayments for insulin at $30 per 30-day supply for those on state-regulated commercial health insurance plans. Improving insulin affordability helps people with diabetes to manage the disease, stay healthy, and reduce their risk for dangerous complications

In a victory for children with disabilities, a federal court ruled today that the City of New York’s Department of Education (“DOE”) routinely denies students with diabetes access to field trips and bus transportation in violation of the Americans with Disabilities Act (“ADA”), Section 504 of the Rehabilitation Act (“Section 504”), and the New York City Human Rights Law (“NYCHRL”). Plaintiffs in this lawsuit are the American Diabetes Association ® (“Association”), the nation’s leading diabetes organization, and three individual students with diabetes who attend New York City schools. Click

The American Diabetes Association ® (ADA) has launched new requests for applications (RFAs) for the Fall 2022 Grant Cycle to research and expand the field of knowledge to improve the lives of those living with diabetes. The critical topics for research include supporting the behavioral and mental health of people with diabetes, tackling the epidemic of youth onset type 2 diabetes, and improving the lives of women living with diabetes. Each topic offers multiple award mechanisms including—postdoctoral fellowships, junior faculty development, innovative basic, and innovative clinical or

Today, the American Diabetes Association® (ADA) and Genentech, a member of the Roche Group, announced a program to increase equitable access to eye health care in the Washington, DC metropolitan area. The program, an extension of the Health Equity Now® initiative, will focus on identifying and removing barriers to care facing Black and Hispanic/Latino communities in the DC region. Diabetes-related eye disease affects nearly 8 million Americans and is the leading cause of vision loss in people 18–64 years old. Black, Native American/Alaska Native, Hispanic/Latino, and older adults living with